Work

Targeting AXL Protein Could Overcome Resistance to Erlotinib in NSCLC

Year: 2012

Type: article

Author: Dave Levitan

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2942850877

FWCI:

Cites:

Cited by:

Related to: 10